Cargando…
Bioenergetics of the Calf Muscle in Friedreich Ataxia Patients Measured by 31P-MRS Before and After Treatment with Recombinant Human Erythropoietin
Friedreich ataxia (FRDA) is caused by a GAA repeat expansion in the FXN gene leading to reduced expression of the mitochondrial protein frataxin. Recombinant human erythropoietin (rhuEPO) is suggested to increase frataxin levels, alter mitochondrial function and improve clinical scores in FRDA patie...
Autores principales: | Nachbauer, Wolfgang, Boesch, Sylvia, Schneider, Rainer, Eigentler, Andreas, Wanschitz, Julia, Poewe, Werner, Schocke, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726701/ https://www.ncbi.nlm.nih.gov/pubmed/23922695 http://dx.doi.org/10.1371/journal.pone.0069229 |
Ejemplares similares
-
A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia
por: Santner, Wolfram, et al.
Publicado: (2014) -
Autonomic function testing in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2018) -
Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023) -
Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023) -
Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
por: Boesch, Sylvia, et al.
Publicado: (2019)